Christopher Coughlin - Dun Bradstreet Non-Executive Chairman of the Board
DNB Stock | USD 9.35 0.11 1.19% |
Chairman
Mr. Christopher J. Coughlin is no longer NonExecutive Director of The Dun Bradstreet Corporationrationration, with effect from May 2017. He was NonExecutive Chairman of the Board of the Company. He was a director of Dun Bradstreet since December 2004. Mr. Coughlin is Chairman of the Nominating Governance Committee and a member of the Compensation Benefits Committee. Mr. Coughlin also served as the Lead Director from August 2010 to October 2013. Mr. Coughlin served as Executive Vice President and Chief Financial Officer of Tyco International Ltd., a global provider of fire protection and security solutions from March 2005 until December 2010 and served as an advisor to Tyco from December 2010 until October 2012. Previously, he served at The Interpublic Group of Companies, Inc. as Executive Vice President and Chief Operating Officer from June 2003 to December 2004, as Chief Financial Officer from August 2003 to June 2004, and as a director from July 2003 to July 2004. Prior to that, Mr. Coughlin served as Executive Vice President and Chief Financial Officer of Pharmacia Corporation from 1998 to 2003, and prior to that Mr. Coughlin served as Executive Vice President and then President of Nabisco International, a division of Nabisco Holdings. Mr. Coughlin currently serves as a Senior Advisor to McKinsey Company and is also a director of the following public companies Allergan plc, Alexion Pharmaceuticals, Inc. and Hologic, Inc. In the last five years he served as a director of the following public companies Covidien plc, Forest Laboratories, Inc. and Dipexium Pharmaceuticals, Inc. Prior to that, he served as a director of Perrigo Company, Monsanto Company and The Interpublic Group of Companies, Inc. Mr. Coughlin financial expertise and general management and operations experience gained from his executive officerchief financial officer positions at four large public companies. since 2016.
Age | 62 |
Tenure | 8 years |
Address | 5335 Gate Parkway, Jacksonville, FL, United States, 32256 |
Phone | 904 648 8006 |
Web | https://www.dnb.com |
Christopher Coughlin Latest Insider Activity
Tracking and analyzing the buying and selling activities of Christopher Coughlin against Dun Bradstreet stock is an integral part of due diligence when investing in Dun Bradstreet. Christopher Coughlin insider activity provides valuable insight into whether Dun Bradstreet is net buyers or sellers over its current business cycle. Note, Dun Bradstreet insiders must abide by specific rules, including filing SEC forms every time they buy or sell Dun Bradstreet'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Christopher Coughlin over a month ago Disposition of 436 shares by Christopher Coughlin of Timken at 81.5 subject to Rule 16b-3 |
Dun Bradstreet Management Efficiency
The company has Return on Asset of 0.0115 % which means that on every $100 spent on assets, it made $0.0115 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0126) %, meaning that it generated no profit with money invested by stockholders. Dun Bradstreet's management efficiency ratios could be used to measure how well Dun Bradstreet manages its routine affairs as well as how well it operates its assets and liabilities. As of April 29, 2024, Return On Tangible Assets is expected to decline to -0.04. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, Dun Bradstreet's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 287.3 M, whereas Net Tangible Assets are forecasted to decline to (4.6 B).Similar Executives
Showing other executives | CHAIRMAN Age | ||
Terrence Duffy | CME Group | 66 | |
John Tuttle | Intercontinental Exchange | N/A | |
Robin Abrams | FactSet Research Systems | 69 | |
Yi Lee | Intercontinental Exchange | N/A | |
Borje Ekholm | Nasdaq Inc | 52 | |
Leo Melamed | CME Group | 84 | |
Richard Thornburgh | SP Global | 69 | |
Henry McKinnell | Moodys | 77 | |
Charles Vice | Intercontinental Exchange | 55 | |
Joseph Mansueto | Morningstar | 68 | |
Jeffrey Sprecher | Intercontinental Exchange | 69 | |
Charles Carey | CME Group | 64 | |
Joe Mansueto | Morningstar | 58 | |
Charles Haldeman | SP Global | 71 | |
Henry Fernandez | MSCI Inc | 66 | |
Philip Hadley | FactSet Research Systems | 55 |
Management Performance
Return On Equity | -0.0126 | |||
Return On Asset | 0.0115 |
Dun Bradstreet Holdings Leadership Team
Elected by the shareholders, the Dun Bradstreet's board of directors comprises two types of representatives: Dun Bradstreet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dun. The board's role is to monitor Dun Bradstreet's management team and ensure that shareholders' interests are well served. Dun Bradstreet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dun Bradstreet's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Copelyn, Non-Executive Chairman of the Board | ||
Curtis Brown, CIO | ||
Mohamed Ahmed, Lead Independent non-executive Director | ||
Ingjerd Spiten, Group Executive Vice President Personal Banking | ||
Christie Hill, Corporate Secretary, Chief Legal Officer | ||
Alf Otterstad, Group Executive Vice President IT | ||
Virginia Gomez, Chief Product Officer | ||
Rich Kulesa, Chief Officer | ||
Gysbert Wege, CFO, Director | ||
Joshua Peirez, Pres and COO | ||
Anastassia Lauterbach, Director | ||
KarlChristian Agerup, Independent Director | ||
Faith Mahloma, Non-Executive Independent Director | ||
James Quella, Independent Director | ||
Roslynn Williams, Chief People Officer | ||
Cindy Christy, Director | ||
Michael Bird, President - Sales and Marketing Solutions | ||
Rishi Dave, Chief Marketing Officer | ||
Kevin Coop, Chief Commercial Officer | ||
Hakon Hansen, Executive Vice President Wealth Management & Insurance | ||
Jaan Semlitsch, Independent Director | ||
Ottar Ertzeid, Group Executive Vice President Markets | ||
Carl Lovvik, Director, Employee Representative | ||
Kathy Guinnessey, IR Contact Officer | ||
Harald SerckHanssen, Group Executive Vice President Large Corporates and International | ||
Neeraj Sahai, President - International | ||
Amon Ntuli, Executive Director | ||
Thomas Hagerty, Independent Director | ||
Tore Rimmereid, Independent Vice Chairman of the Board | ||
Solveig Hellebust, Group Executive Vice President People & Operations | ||
Anthony Jabbour, Chief Executive Officer, Director | ||
Bryan Hipsher, Chief Financial Officer, Executive Vice President, Treasurer | ||
Joe Reinhardt, Chief Legal Officer | ||
David Duncan, COO, Director | ||
Kjerstin Braathen, CFO | ||
Avinash Gupta, Managing India | ||
William Foley, Non-Executive Chairman of the Board | ||
Paul Garcia, Independent Director | ||
Vigdis Mathisen, Director, Employee Representative | ||
Mirella Wassiluk, Group Executive Vice President Compliance | ||
Gro Bakstad, Director | ||
Michael Manos, Chief Technology Officer | ||
Berit Svendsen, Independent Director | ||
Gary Kotovets, Chief Data Officer | ||
Andrew Hausman, President - Finance & Risk Solutions | ||
James Fernandez, Independent Director | ||
Rune Bjerke, Group CEO | ||
Richard Veldran, CFO | ||
Yunis Shaik, Non-Executive Director | ||
Rasmus Figenschou, Group Executive Vice President New Business | ||
Naziema Jappie, Independent non-executive Director | ||
Rune Helland, Head of Investor Relations | ||
Gil Shaked, Chief Technology Officer | ||
Robert Carrigan, CEO and Director | ||
Ganesh Rao, Independent Director | ||
Keith Jackson, Independent Director | ||
Richard Massey, Independent Director | ||
Thomas Manning, Director | ||
Michele Caselnova, Chief Officer | ||
Randall Mott, Director | ||
Brian Alster, Gen Compliance | ||
Douglas Ammerman, Independent Director | ||
Mark Geneste, Chief Sales Officer | ||
Ellen Alemany, Director | ||
Stuart Queen, CEO, Director | ||
Thomas Rauker, Chief Operations Officer | ||
Chinh Chu, Director | ||
William II, Executive Chairman | ||
CIPPUS CIPPE, Chief Officer | ||
Christopher Coughlin, Non-Executive Chairman of the Board | ||
Ida Lerner, Group Executive Vice President Group Risk Management | ||
Anthony Pietrontone, Chief Controller | ||
Benedicte Fasmer, Group Executive Vice President Corporate Banking | ||
Stephen Daffron, President | ||
Judith Reinsdorf, Director | ||
Cheryl Philip, Company Secretary | ||
Thomas Midteide, Group Executive Vice President Media & Marketing | ||
Joseph III, Chief Officer | ||
Gordon Crovitz, Director | ||
Suchitra Gupta, Chief Analytics Officer | ||
Rachel Watson, Non-Executive Director | ||
Olaug Svarva, Chairman of the Board |
Dun Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dun Bradstreet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0126 | |||
Return On Asset | 0.0115 | |||
Profit Margin | (0.02) % | |||
Operating Margin | 0.11 % | |||
Current Valuation | 7.49 B | |||
Shares Outstanding | 442.72 M | |||
Shares Owned By Insiders | 8.91 % | |||
Shares Owned By Institutions | 93.82 % | |||
Number Of Shares Shorted | 13.19 M | |||
Price To Earning | 29.64 X |
Pair Trading with Dun Bradstreet
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dun Bradstreet position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dun Bradstreet will appreciate offsetting losses from the drop in the long position's value.Moving together with Dun Stock
0.63 | FA | First Advantage Corp Financial Report 8th of May 2024 | PairCorr |
Moving against Dun Stock
0.87 | VLTO | Veralto | PairCorr |
0.87 | VSEC | VSE Corporation Financial Report 6th of May 2024 | PairCorr |
0.83 | MG | Mistras Group | PairCorr |
0.83 | NL | NL Industries | PairCorr |
0.82 | WM | Waste Management | PairCorr |
The ability to find closely correlated positions to Dun Bradstreet could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dun Bradstreet when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dun Bradstreet - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dun Bradstreet Holdings to buy it.
The correlation of Dun Bradstreet is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dun Bradstreet moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dun Bradstreet Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dun Bradstreet can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dun Bradstreet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Dun Stock analysis
When running Dun Bradstreet's price analysis, check to measure Dun Bradstreet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dun Bradstreet is operating at the current time. Most of Dun Bradstreet's value examination focuses on studying past and present price action to predict the probability of Dun Bradstreet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dun Bradstreet's price. Additionally, you may evaluate how the addition of Dun Bradstreet to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Dun Bradstreet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dun Bradstreet. If investors know Dun will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dun Bradstreet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.92) | Dividend Share 0.2 | Earnings Share (0.11) | Revenue Per Share 5.375 | Quarterly Revenue Growth 0.06 |
The market value of Dun Bradstreet Holdings is measured differently than its book value, which is the value of Dun that is recorded on the company's balance sheet. Investors also form their own opinion of Dun Bradstreet's value that differs from its market value or its book value, called intrinsic value, which is Dun Bradstreet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dun Bradstreet's market value can be influenced by many factors that don't directly affect Dun Bradstreet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dun Bradstreet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dun Bradstreet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dun Bradstreet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.